Overall, the gene expression analysis reveals that Brca2-deficient MBs have a gene expression program similar to P7 GCPs but also acquire additional expression changes that may promote tumor growth through pathways divergent from those active during normal GCP proliferation. Here, BRCA2 is linked to neoplasm.